Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa - Top-Institutions - MDSpire

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

  • By

  • Juling Sia

  • Bernett Lee

  • Hazel H. Oon

  • April 22, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Dermatology
    • Immunology
    • Clinical Trials

  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Dermatology
    • Immunology
    • Translational Medicine

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Dermatology
    • Rheumatology
    • Clinical Research

  • #4

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Dermatology
    • Immunology
    • Inflammatory Disease Research

  • #5

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Immunology
    • Clinical Trials

Original Source(s)

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

  • by Juling Sia, Bernett Lee, Hazel H. Oon

  • April 22, 2026

Related Content

HS Linked to Higher Self-Harm, Suicide Risk

Prior self-harm episodes and nonviolent methods are more common among HS patients who die by suicide, new research finds.

Exploring Addictive Behaviors in Patients with Hidradenitis Suppurativa: Findings from a Cross-Sectional Pilot Study

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.